This funding opportunity supports the development of innovative, reliable, and cost-effective AI-based clinical decision support tools that integrate clinical imaging with multimodal health data. It aims to catalyze the translation of these AI-enabled tools from prototype testing to clinical applications addressing unmet health challenges in precision medicine, with potential for significant impact on patient outcomes and healthcare processes. Clinical trial participation is optional.
Eligible applicants include a wide range of organizations such as nonprofits, institutions of higher education, tribal organizations, government entities, small businesses, and foreign organizations. Both domestic and non-domestic entities may apply, including foreign components of U.S. organization
